University of Tennessee Health Science Center
Regulation of CYP3A5 in Pancreatic Ductal Adenocarcinoma
Abstract
dc:description.abstract<p>CYP3A5 is a drug metabolism enzyme that is polymorphically expressed in normal tissues and expressed in high amounts in some cancers, including pancreatic ductal adenocarcinoma (PDAC). There have been several published studies regarding CYP3A5 regulators, but there is still much to be discovered concerning CYP3A5 regulation in cancer. To further understand the regulation of CYP3A5, a high-throughput screen was performed in the AsPC-1 PDAC cell line. This screen employed small interfering RNA (siRNA) targeting transcription factors and chromatin-associated proteins. We identified siRNA that decreased CYP3A5 mRNA and protein levels in AsPC-1 cells and probed into the potential mechanisms. Taken together, this study brought to light a previously undescribed regulator of CYP3A5 expression.</p>
Degree
thesis:*- Name thesis:degree_name
- Master of Science (MS)
- Level thesis:degree_level
- Thesis
- Discipline thesis:degree_discipline
- Biomedical Sciences
- Year dc:date.available
- 2019
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Hoyer, Jessica D.
- Contributors dc:contributor
-
- Taosheng Chen, Ph.D.
Subjects
dc:subject × 4Identifiers
dc:identifier.*- Repository record dc:identifier
- https://dc.uthsc.edu/dissertations/483
- OAI identifier oai:identifier
- oai:dc.uthsc.edu:dissertations-1483